| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2024 | 11 | 410,084 | ACLX, SPRY, CRSP, DSGN | 13F-HR | 2/13/2025 | 000095012325002049 |
| Q3 2024 | 11 | 498,734 | ACLX, Zenas BioPharma, Inc, SPRY, CRSP | 13F-HR | 11/13/2024 | 000095012324011277 |
| Q2 2024 | 9 | 319,401 | ACLX, CRSP, SPRY, Alumis Inc. | 13F-HR | 8/13/2024 | 000095012324008225 |
| Q1 2024 | 6 | 364,088 | ACLX, CRSP, SPRY, NKTX | 13F-HR | 5/13/2024 | 000191026424000003 |
| Q4 2023 | 5 | 238,157 | ACLX, SPRY, DSGN, MLYS | 13F-HR | 2/12/2024 | 000191026424000001 |
| Q3 2023 | 6 | 195,121 | ACLX, MLYS, DSGN, SPRY | 13F-HR | 11/13/2023 | 000191026423000007 |
| Q2 2023 | 6 | 231,907 | ACLX, DSGN, MLYS, SPRY | 13F-HR | 8/10/2023 | 000191026423000005 |
| Q1 2023 | 6 | 268,461 | ACLX, DSGN, MLYS, SPRY | RESTATEMENT | 5/19/2023 | 000191026423000003 |
| Q4 2022 | 5 | 273,944 | ACLX, DSGN, SPRY, NKTX | 13F-HR | 2/8/2023 | 000191026423000001 |
| Q3 2022 | 4 | 218,746 | ACLX, DSGN, NKTX, EFTR | 13F-HR | 11/8/2022 | 000191026422000004 |
| Q2 2022 | 4 | 204,325 | ACLX, DSGN, NKTX, EFTR | 13F-HR | 8/1/2022 | 000191026422000003 |
| Q1 2022 | 3 | 195,335 | DSGN, ACLX, EFTR | 13F-HR | 5/10/2022 | 000191026422000002 |
| Q4 2021 | 2 | 176,950 | DSGN, EFTR | 13F-HR | 2/14/2022 | 000191026422000001 |